A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
Clinical trial NCT01076075 · COMPLETED
Trial details
- NCT number
- NCT01076075
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-03
- Primary completion
- 2011-07-11
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.